News + Filings Transactions Holdings
All 13F 13D/G Other
|
Omega Fund VI, L.P.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
02/13/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2022 |
SC 13G/A
| Omega Fund VI, L.P. reports a 8.2% stake in Alpine Immune Sciences, Inc. |
02/14/2022 |
SC 13G
| Omega Fund VI, L.P. reports a 6.3% stake in § 240.13d-2 Ikena Oncology, Inc. |
02/14/2022 |
SC 13G
| Omega Fund VI, L.P. reports a 9% stake in § 240.13d-2 Imago BioSciences, Inc. |
10/14/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
07/20/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/15/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
02/12/2021 |
SC 13G
| Omega Fund VI, L.P. reports a 6.2% stake in § 240.13d-2 Checkmate Pharmaceuticals, Inc. |
02/12/2021 |
SC 13G
| Omega Fund VI, L.P. reports a 9.3% stake in § 240.13d-2 Spruce Biosciences, Inc. |
01/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/06/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
10/16/2020 |
4
| Omega Fund VI, L.P. (Former 10% Owner) has filed a Form 4 on SPRUCE BIOSCIENCES, INC.
Txns:
| Converted 1,911,022 shares
@ $0 Bought 250,000 shares
@ $15, valued at
$3.8M
Converted 12,500,000 preferred shares
@ $0 |
|
10/08/2020 |
3
| Omega Fund VI, L.P. (10% Owner) has filed a Form 3 on SPRUCE BIOSCIENCES, INC. |
|
|